A Phase 1 Study of BMS-986453 in Participants with Relapsed and/or Refractory Multiple Myeloma

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506003-26-00

Acronym

CA1190002

Enrollment

Registered

2024-11-19

Start date

2024-11-27

Completion date

Unknown

Last updated

2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed and/or Refractory Multiple Myeloma

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Germany, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026